StocksMedium•25 October 2026•
1 min read
Shanghai Haohai Biological Margins Shrink to 4.9% Amid Revenue Decline
Key Facts
1Shanghai Haohai Biological's trailing 12-month net margin compressed to 4.9% from 15.3% a year earlier.
2Quarterly net income reached CN¥50.27m, while revenue fell to CN¥531.3m compared to CN¥606.4m in the prior year.
3Profitability was impacted by a CN¥194.6m one-off loss.
Shanghai Haohai Biological's trailing 12-month net margin compressed to 4.9% from 15.3% in the previous year. Yahoo Finance reported that the company's quarterly net income reached CN¥50.27m, as revenue declined to CN¥531.3m from CN¥606.4m in the prior-year period.
Profitability was significantly impacted by a one-off exceptional loss of CN¥194.6m. This downturn in financial performance reflects broader pressure on total revenues, which contributed to the tightening of operational margins for the healthcare sector firm.